Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2,527,521,347
-
Number of holders
-
2,943
-
Total 13F shares, excl. options
-
1,649,092,734
-
Shares change
-
+33,013,183
-
Total reported value, excl. options
-
$150,418,545,265
-
Value change
-
+$3,013,097,666
-
Put/Call ratio
-
78%
-
Number of buys
-
1,459
-
Number of sells
-
-1,162
-
Price
-
$91.17
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2022
3,150 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2022.
Merck & Co., Inc. - Common Stock (MRK) has 2,943 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,649,092,734 shares
of 2,527,521,347 outstanding shares and own 65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (221,053,046 shares), STATE STREET CORP (117,791,629 shares), GEODE CAPITAL MANAGEMENT, LLC (45,994,668 shares), WELLINGTON MANAGEMENT GROUP LLP (40,723,427 shares), BANK OF AMERICA CORP /DE/ (38,894,000 shares), MORGAN STANLEY (37,975,483 shares), Bank of New York Mellon Corp (32,580,475 shares), NORTHERN TRUST CORP (29,949,687 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (29,520,911 shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (27,720,086 shares).
This table shows the top 2,943 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.